CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 113 filers reported holding CONCERT PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 1.73 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $15,000 | -21.1% | 4,501 | +0.6% | 0.00% | – |
| Q2 2021 | $19,000 | -9.5% | 4,472 | +8.5% | 0.00% | – |
| Q1 2021 | $21,000 | +23.5% | 4,123 | +191.4% | 0.00% | – |
| Q1 2019 | $17,000 | -43.3% | 1,415 | -41.5% | 0.00% | – |
| Q4 2018 | $30,000 | -16.7% | 2,419 | 0.0% | 0.00% | – |
| Q3 2018 | $36,000 | -12.2% | 2,419 | 0.0% | 0.00% | – |
| Q2 2018 | $41,000 | -25.5% | 2,419 | 0.0% | 0.00% | – |
| Q1 2018 | $55,000 | -62.6% | 2,419 | -57.3% | 0.00% | -100.0% |
| Q4 2017 | $147,000 | +110.0% | 5,668 | +19.9% | 0.00% | 0.0% |
| Q3 2017 | $70,000 | +6.1% | 4,728 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $66,000 | -18.5% | 4,728 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $81,000 | +65.3% | 4,728 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $49,000 | – | 4,728 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 2,253,000 | $7,097,000 | 0.26% |
| INGALLS & SNYDER LLC | 1,358,573 | $4,280,000 | 0.19% |
| RA Capital Management | 3,033,603 | $9,556,000 | 0.17% |
| Kensington Investment Counsel, LLC | 85,483 | $269,000 | 0.16% |
| Perceptive Advisors | 4,301,282 | $13,548,000 | 0.10% |
| NewEdge Wealth, LLC | 381,326 | $1,201,000 | 0.05% |
| Black Diamond Financial, LLC | 46,000 | $145,000 | 0.05% |
| Birchview Capital, LP | 20,000 | $63,000 | 0.04% |
| XTX Topco Ltd | 14,305 | $45,000 | 0.02% |
| Alyeska Investment Group, L.P. | 548,090 | $1,726,000 | 0.02% |